Skip to main content
SpringerLink
Log in
Book cover

Drugs for the Treatment of Parkinson’s Disease

  • Book
  • © 1989
Download book PDF

Overview

Editors:
  1. Donald B. Calne

    1. Division of Neurology, UBC Health Sciences Centre Hospital, Vancouver, Canada

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 88)

Buy print copy

Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Table of contents (24 chapters)

  1. Front Matter

    Pages I-XXIV
    Download chapter PDF

  2. Neurophysiology of Basal Ganglia

    • W. Schultz
    Pages 1-45
    Download chapter PDF

  3. Pathology of Parkinson’s Syndrome

    • K. Jellinger
    Pages 47-112
    Download chapter PDF

  4. Biochemical Neuroanatomy of the Basal Ganglia

    • E. G. McGeer, P. L. McGeer
    Pages 113-148
    Download chapter PDF

  5. Receptors in the Basal Ganglia

    • A. B. Young, J. B. Penney
    Pages 149-163
    Download chapter PDF

  6. Imaging the Basal Ganglia

    • W. R. W. Martin
    Pages 165-183
    Download chapter PDF

  7. The Neurochemical Basis of the Pharmacology of Parkinson’s Disease

    • O. Hornykiewicz
    Pages 185-204
    Download chapter PDF

  8. Pyridine Toxins

    • J. W. Langston, I. Irwin
    Pages 205-226
    Download chapter PDF

  9. The Relationship Between Parkinson’s Disease and Other Movement Disorders

    • J. Jankovic
    Pages 227-270
    Download chapter PDF

  10. Evaluation of Parkinson’s Disease

    • H. Teräväinen, J. Tsui, D. B. Calne
    Pages 271-279
    Download chapter PDF

  11. Clinical Trials for Parkinson’s Disease

    • J. K. Tsui, H. Teräväinen, D. B. Calne
    Pages 281-288
    Download chapter PDF

  12. Experimental Therapeutics Directed at the Pathogenesis of Parkinson’s Disease

    • I. Shoulson
    Pages 289-305
    Download chapter PDF

  13. Anticholinergic Drugs and Amantadine in the Treatment of Parkinson’s Disease

    • A. E. Lang, R. D. G. Blair
    Pages 307-323
    Download chapter PDF

  14. The Pharmacology of Levodopa in Treatment of Parkinson’s Disease: An Update

    • P. A. LeWitt
    Pages 325-384
    Download chapter PDF

  15. Adverse Effects of Levodopa in Parkinson’s Disease

    • S. Fahn
    Pages 385-409
    Download chapter PDF

  16. Monoamine Oxidase Inhibitors in Parkinson’s Disease

    • M. Sandler, V. Glover
    Pages 411-431
    Download chapter PDF

  17. Clinical Actions of l-Deprenyl in Parkinson’s Disease

    • M. D. Yahr, H. Kaufmann
    Pages 433-441
    Download chapter PDF

  18. Update on Bromocriptine in Parkinson’s Disease

    • A. N. Lieberman, M. Goldstein
    Pages 443-458
    Download chapter PDF

  19. Pergolide in the Treatment of Parkinson’s Disease

    • C. H. Markham, S. G. Diamond
    Pages 459-470
    Download chapter PDF

  20. Lisuride Pharmacology and Treatment of Parkinson’s Disease

    • G. Gopinathan, R. Horowski, I. H. Suchy
    Pages 471-513
    Download chapter PDF
Back to top

Keywords

Editors and Affiliations

  • Division of Neurology, UBC Health Sciences Centre Hospital, Vancouver, Canada

    Donald B. Calne

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation